Clinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy

Zhi-Hua Zhang1, Fan-Qi Meng2, Xiao-Feng Hou3

  • 1Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu, China; Department of Cardiology, Jiangning Hospital Affiliated to Nanjing Medical University, Jiangsu, China.

Indian Heart Journal
|June 15, 2020
PubMed

Insights

Prognostic risk factors differ between ischemic (ICM) and non-ischemic (NICM) heart failure. Identifying these distinct predictors is crucial for improving patient outcomes and guiding clinical management strategies.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Heart failure (HF) prognosis varies significantly based on its underlying cause.
  • Differentiating between ischemic cardiomyopathy (ICM) and non-ischemic cardiomyopathy (NICM) is essential for accurate risk stratification.
  • Understanding specific prognostic factors for each HF etiology is clinically valuable.

Purpose of the Study:

  • To explore and identify the distinct predicting factors for prognosis in patients with ICM and NICM.
  • To compare the risk factors associated with all-cause mortality, sudden cardiac death (SCD), and rehospitalization for HF between ICM and NICM.

Main Methods:

  • Retrospective analysis of 873 patients with heart failure with reduced ejection fraction (HFrEF).
  • Patients were categorized into ICM and NICM groups.
  • Multivariate Cox regression analysis was employed to identify independent risk factors for mortality, SCD, and rehospitalization.

Main Results:

  • Patients with ICM exhibited higher rates of all-cause mortality and SCD compared to NICM.
  • Independent risk factors for all-cause mortality in ICM included diabetes mellitus, previous HF hospitalization, age, eGFR, and LVEF.
  • Distinct predictors for SCD and rehospitalization were identified for both ICM and NICM groups, highlighting etiological differences.

Conclusions:

  • Ischemic heart failure is associated with a worse prognosis, including higher all-cause mortality and SCD rates, than non-ischemic heart failure.
  • The risk factors influencing the prognosis of heart failure are significantly different depending on the underlying etiology (ICM vs. NICM).
Abstract

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
383
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
319
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
263
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
214
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
337
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
261